Times Radio: Research Finds New Positive Impacts of Semaglutide

More than 10 studies presented at the European Society of Cardiology Congress revealed new findings on the far-reaching benefits of semaglutide.

Times Radio talked to talked to Dr. Mikhail Kosiborod, cardiologist and vice president of research at Saint Luke's Mid America Heart Institute who has published several studies on the medications, about what the research reveals.  

Related Content

Sep. 6, 2024

BBC News: Studies Reveal New Effects of Semaglutide
BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.
Sep. 6, 2024

BBC Radio: Research Shows New Effects of Semaglutide
Recently published studies have found new effects of semaglutide, including reduced risk of heart conditions and the potential for a reduced risk of cardiovascular death.
Sep. 4, 2024

Healio: Semaglutide Cuts Risk for Worsening Heart Failure, CV Death Among Adults with HFpEF
Semaglutide cut the risk for worsening heart failure and cardiovascular death for adults with heart failure with preserved ejection fraction, according to new data presented by Dr. Mikhail Kosiborod.